ILMN - Illumina Inc logo

Illumina Inc

ILMN

Illumina Inc. develops and markets sequencing and array-based solutions for genetic analysis, providing instruments, consumables, and services to genomic research centers, hospitals, and pharmaceutical companies. Key offerings include whole-genome sequencing kits and genotyping services.

โš•๏ธ Healthcare NASDAQ Listed 2000 $ USD
$1,000 invested 20 years ago โ†’$10,329today

Score Overview

1 Year
Score
Net Growth5.29%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth4.63%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score4.6
Net Growth17.45%
Net Trend60%
Net Income Consistencyโ€”
Rev Growth0.29%
Rev Trend40%
Revenue Consistencyโ€”
10 Years
Score
Net Growth93.45%
Net Trend70%
Net Income Consistency
Rev Growth89.25%
Rev Trend60%
Revenue Consistency
20 Years
Score7.2
Net Growth22x
Net Trend70%
Net Income Consistency
Rev Growth24x
Rev Trend80%
Revenue Consistency
All Time
Score
Net Growth50x
Net Trend65%
Net Income Consistency
Rev Growth3467x
Rev Trend85%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Illumina Inc has ranked, year by year

Measure
Fundamentals Window

Showing 10 years ranking history by HDB Score.

Reached the top 50 on HDB Score in 3 years, the longest run being 3 in a row โ€” but not in 2021.

  • ILMN

2011: 33.7% ยท 2021: 6.5% ยท free through 2021 ยท longest runs

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-11-17
$ 202.61โ€”
1 Year2025-11-17
$ 120.0868.73%
5 Years2021-11-17
$ 367.34-44.84%
10 Years2016-11-17
$ 130.4455.33%
20 Years2006-11-17
$ 19.6210x
All Time2000-07-28
$ 19.0510x

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 4.53B$ 895M$ 1.33B
2025$ 4.33B$ 850M$ 1.63B
2024$ 4.37B-$ 1.22B$ 1.22B
2023$ 4.50B-$ 1.16B$ 1.05B
2022$ 4.58B-$ 4.40B$ 2.03B
2021$ 4.52B$ 762M$ 1.33B
2020$ 3.23B$ 656M$ 3.47B
2019$ 3.54B$ 1.00B$ 3.41B
2018$ 3.33B$ 826M$ 3.51B
2017$ 2.75B$ 726M$ 2.14B
2016$ 2.39B$ 462M$ 1.55B
2015$ 2.21B$ 461M$ 1.38B
2014$ 1.86B$ 353M$ 1.33B
2013$ 1.42B$ 125M$ 1.16B
2012$ 1.14B$ 151M$ 1.35B
2011$ 1.05B$ 86M$ 1.18B
2010$ 902M$ 124M$ 894M
2009$ 666M$ 72M$ 693M
2008$ 573M$ 50M$ 640M
2007$ 366M-$ 278M$ 386M
2006$ 184M$ 39M$ 130M
2005$ 73M-$ 20M$ 50M
2004$ 50M-$ 6M$ 54M
2003$ 28M-$ 27M$ 32M
2002$ 10M-$ 40M$ 53M
2001$ 2M-$ 24M$ 90M
IPO2000$ 1M-$ 18M$ 117M
ILMN - Illumina Inc logo

Illumina Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 3.23B to $ 4.33B and net income grew from $ 656M to $ 850M. Revenue increased in 2 of those 5 years; net income in 3.

Across Illumina Inc's full reported history, from 2000 to 2025, revenue grew from $ 1M to $ 4.33B and net income went from -$ 18M to $ 850M. Revenue increased in 85% of the years measured; net income in 65%.

Illumina Inc currently holds a 20-year HDB Score of 7.2 out of 10. How the HDB Score is calculated.

Membership

Continue ILMNโ€™s history

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,188 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$149 / year

or $19/month

Continue with Membership

30-day money-back guarantee.

Explore other companies